NCT01345214 - A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

February 28, 2014

Conditions

Chemotherapy-Induced Thrombocytopenia

Interventions

DRUG

ONO-7746

10mg, 20mg, 50mg, 100mg, 200mg and 300mg once-daily for 14 days

Trial Locations (14)

Augusta Clinical Site 01-01, Augusta

Ames Clinical Site 07-01, Ames

Fort Collins Clinical Site 13-01, Fort Collins

Moscow Clinical Site 14-01, Moscow

Arkhangelsk Clinical Site 10-01, Arkhangelsk

St. Petersburg Clinical Site 11-01, Saint Petersburg

Tula Clinical Site 12-01, Tula

Tambov Clinical Site 16-01, Tambov

Samara Clinical Site 15-01, Samara

Ufa Clinical Site 17-01, Ufa

Deagu Clinical Site 18-01, Deagu

Jeollanam-do Clinical Site 19-01, Jeollanam-do

Seoul Clinical Site 20-01, Seoul

Seoul Clinical Site 21-01, Seoul